Načítá se...
IL23 secreted by myeloid cells drives castration resistant prostate cancer
Prostate cancer patients frequently experience resistance to androgen deprivation therapy (ADT). Acquiring a better understanding of the mechanisms controlling the development of castration resistant prostate cancer (CRPC) remains an unmet clinical need. The well-established dependency of cancer cel...
Uloženo v:
| Vydáno v: | Nature |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461206/ https://ncbi.nlm.nih.gov/pubmed/29950727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-018-0266-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|